Diagnosis and treatment of the major hepatotropic viruses

P K Kiyasu1, S H Caldwell

  • 1Department of Internal Medicine, University of Virginia, Charlottesville.

Insights

Hepatitis viruses A through E cause liver disease. While A and E cause acute injury, B, C, and D can lead to chronic conditions like cancer, requiring ongoing research for better treatments.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatotropic viruses (Hepatitis A, B, C, D, E) cause diverse liver diseases.
  • Understanding their epidemiology and natural history is crucial for patient management.
  • Evolving diagnostic assays impact the detection and understanding of these infections.

Purpose of the Study:

  • To review the epidemiology, natural history, and clinical presentations of hepatitis viruses A-E.
  • To discuss current and emerging diagnostic and therapeutic strategies.
  • To highlight the impact of these viruses on liver health and disease progression.

Main Methods:

  • Comprehensive literature review of hepatotropic viral infections.
  • Analysis of current serodiagnostic and virologic assay capabilities.
  • Discussion of established and investigational treatment modalities.

Main Results:

  • Hepatitis A and E cause acute liver injury, managed via vaccination.
  • Hepatitis B, C, and D can result in chronic liver disease, including cirrhosis and hepatocellular carcinoma.
  • Interferon is a current therapy, with other antiviral strategies under investigation.
  • Liver transplantation is an option for advanced disease, but viral recurrence is a significant challenge.

Conclusions:

  • Continued molecular, epidemiologic, and clinical research is essential for improved diagnosis and management of viral hepatitis.
  • Vaccination remains key for preventing Hepatitis A and E.
  • Effective management of chronic Hepatitis B, C, and D requires ongoing therapeutic innovation and strategies to combat viral recurrence post-transplantation.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...